Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04697836
Other study ID # Regional anesthesia
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2020
Est. completion date November 25, 2020

Study information

Verified date January 2021
Source Namik Kemal University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Current healthcare delivery models emphasize enhanced postoperative recovery (ERAS) with minimal morbidity and shorter hospital stays. Most tracheostomy cases are tumour patients. The more the patients have difficulty in breathing, the more difficult it is to anaesthetize them. Adequate intraoperative anaesthesia and postoperative analgesia with minimal sedation play an essential role in this patient model. In tracheostomy patients, moving away from the general anaesthesia option increases airway safety, and avoiding the local anaesthesia option in the incision area increases patient comfort. The purpose of this study is to assess the safety and efficacy of regional anaesthesia in tracheostomy patients.


Description:

after being informed and about the study and potential risks, all patients giving written informed consent will undergo 24 hours screening period to determine the eligilibity for study entry. After a computer-generated randomization list with a 1:1 intergroup ratio, ensuring equal distribution in the two groups, 30 opaque sealed envelopes numbered 1-30 were prepared. The patients were randomly divided into the Group with bilateral CPB with 15 ml 0.5% bupivacaine or the patients with translaryngeal block with 5 ml 2% lidocaine in addition to bilateral CPB. CPB: cervical plexus block.


Recruitment information / eligibility

Status Completed
Enrollment 29
Est. completion date November 25, 2020
Est. primary completion date November 25, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Being in the age range of 18-65, with American Society of Anesthesiology (ASA) classification I-III and scheduled for elective or emergency tracheostomy. - A sufficient level of education to understand the study procedures and agree to participate in the study Exclusion Criteria: - inability to cooperate - dementia, - allergy to local anesthetics and opioids - regular daily opioid requirements - abuse of alcohol or medication - local infection at the site of injection or systemic infection, - pregnancy.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
ST
After a computer-generated randomization list with a 1:1 intergroup ratio, ensuring equal distribution in the two groups, 30 opaque sealed envelopes numbered 1-30 were prepared. The patients were randomly divided into the Group with bilateral CPB with 15 ml 0.5% bupivacaine or the patients with translaryngeal block with 5 ml 2% lidocaine in addition to bilateral CPB. Following inclusion, two research assistants, with no further involvement in the study, prepared 15mL syringes and 5 ml syringes according to the envelope's specifications. The syringes were marked with the patient's randomization number. All other investigators, staff, and patients were blinded to group allocations. Before surgery, the patients were transferred to the specified block room area monitored with 3-lead electrocardiography, pulse oximetry, and non-invasive blood pressure. All patients had two intravenous cannula lines, and then bilateral CPB block procedures were performed in awake non-sedated patients.

Locations

Country Name City State
Turkey Namik Kemal University Tekirdag Süleymanpasa

Sponsors (1)

Lead Sponsor Collaborator
Namik Kemal University

Country where clinical trial is conducted

Turkey, 

References & Publications (5)

Bradley PJ. Treatment of the patient with upper airway obstruction caused by cancer of the larynx. Otolaryngol Head Neck Surg. 1999 May;120(5):737-41. Review. — View Citation

Freeman BD. Indications for and management of tracheostomy. In: Vincent JL, Abraham E, Moore FA, et al, editors. Textbook of critical care. 6th edition. Phila- delphia: Elsevier/W. B. Saunders; 2011. p. 369-72

Kim JS, Ko JS, Bang S, Kim H, Lee SY. Cervical plexus block. Korean J Anesthesiol. 2018 Aug;71(4):274-288. doi: 10.4097/kja.d.18.00143. Epub 2018 Jul 4. — View Citation

Mehta AB, Syeda SN, Bajpayee L, Cooke CR, Walkey AJ, Wiener RS. Trends in Tracheostomy for Mechanically Ventilated Patients in the United States, 1993-2012. Am J Respir Crit Care Med. 2015 Aug 15;192(4):446-54. doi: 10.1164/rccm.201502-0239OC. — View Citation

Moorthy SS, Gupta S, Laurent B, Weisberger EC. Management of airway in patients with laryngeal tumors. J Clin Anesth. 2005 Dec;17(8):604-9. doi: 10.1016/j.jclinane.2004.12.019. Erratum in: J Clin Anesth. 2006 Mar;18(2):163-4. PMID: 16427530

Outcome

Type Measure Description Time frame Safety issue
Primary pain score (NRS) A numerical rating scale (NRS) requires the patient to rate their pain on a defined scale. For example, 0-10 where 0 is no pain and 10 is the worst pain imaginable 24 hours
Primary pain related to incision A numerical rating scale (NRS) requires the patient to rate their pain on a defined scale. For example, 0-10 where 0 is no pain and 10 is the worst pain imaginable 24 hours
Primary Patient tolerance as assessed by tracheostomy cannula comfort score = No reaction
= Slight grimacing
= Heavy grimacing
= Defensive movement of hands 5= Flexion of the head with defense
24 hours
Primary cough and gag score = None
= Slight
= Moderate
= Severe
24 hours
Primary nausea and vomiting YES/NO 24 hours
Primary time to first analgesic demand Time of first analgesic need within the first 24 hours 0: within the first 12 hours
1: 12-24 hours
24 hours from the pacu
See also
  Status Clinical Trial Phase
Completed NCT06005480 - Understanding Rebound Pain After Regional Anesthesia Resolution in Healthy Volunteers Phase 1
Completed NCT04565093 - Efficacy of iPACK After Unilateral TKA N/A
Recruiting NCT06074471 - Motor Sparing Supraclavicular Block N/A
Completed NCT03740815 - Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection N/A
Completed NCT02524652 - Local Infiltration Analgesia vs Adductor Canal Block for Analgesia After Anterior Cruciate Ligament Reconstruction Phase 4
Completed NCT03913429 - Ultrasound-guided Bilateral Suprazygomatic Maxillary Nerve Block and Bimaxillary Osteotomy N/A
Completed NCT05012332 - Local Anesthesia Spread After an Erector Spinae Plane Block. N/A
Withdrawn NCT04015284 - Intraoperative Pain and Quality of Surgical Block During Shoulder Surgery Assessed by NOL Index N/A
Recruiting NCT05432934 - Transversus Abdominis Plane Blocks With and Without Dexamethasone Phase 1/Phase 2
Recruiting NCT05512897 - Does ESP Block Reduce Pain and Opiates Consumption After Surgery N/A
Completed NCT04085263 - Rhomboid Intercostal and Subserratus Plane Block N/A
Not yet recruiting NCT04001387 - Feasibility of Real-time Ultrasound-guided Spinal Anesthesia Using Dynamic Needle Tip Positioning
Active, not recruiting NCT05478629 - Safety of Regional Anesthesia in Ukraine: the Survey
Terminated NCT03296033 - Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin Phase 4
Withdrawn NCT02603900 - Adductor Canal Catheter vs Local Infiltration of Analgesia for Total Knee Arthroplasty Phase 4
Completed NCT03666845 - Plasma Ropivacaine Concentrations After Sciatic Nerve Block in Patients With Chronic Kidney Disease
Completed NCT03394807 - LaGRA Trial in Laparoscopic Cholecystectomy Phase 4
Completed NCT05558449 - Impact of Virtual Reality Hypno-sedation on Functional Recovery and Anxiety in Foot Surgery With Regional Anesthesia Phase 4
Completed NCT02433561 - Intra- Versus Extraplexic Catheter Placement for Continuous Interscalene Brachial Plexus Block Phase 4
Recruiting NCT06147401 - Comparison of PENG Associated With LFCN Block Versus FICB for Multimodal Analgesic Management in THA N/A